Ads
related to: us patent
Search results
CIOs take note: Platform engineering teams are the future core of IT orgs
CIO· 2 days agoIT leaders are reassessing organizational structures to be more on the front foot regarding strong...
Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of...
Digital Journal· 7 days agoAeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical ...
Drugmaker Apotex accuses Amarin of Vascepa monopoly in US lawsuit
Reuters· 3 days agoDrugmaker Apotex has sued its rival Amarin in federal court in New Jersey, accusing it of thwarting...
A Win for Trump — and Free Speech — at the Supreme Court
Bloomberg· 7 days agoThe justices resolved a trademark dispute over “Trump too small” shirts by saying peddle whatever...
Safe Pro Group Invited to Participate in the Amazon Web Services Public Sector Summit in Washington,...
Digital Journal· 2 days agoCompany's Attendance to Highlight the Power of Generative AI and its SpotlightAI™ Drone Imagery Analysis Ecosystem Built on Amazon Web Services AVENTURA, FL / ACCESSWIRE / June 18, 2024 / Safe Pro Group Inc. (Safe Pro or the Company), a U.S.-based
Supreme Court rejects ‘Trump Too Small’ trademark - ABC17NEWS
ABC17 NEWS· 7 days agoJustice Clarence Thomas wrote the majority opinion for a unanimous court. The dispute can be traced back to a memorable squabble between then-candidate Donald Trump and Florida GOP Sen. Marco ...
International Threats To The Value Of American Patents
Forbes· 1 day agoIn my last Forbes commentary, I documented the weakening over the last few decades of the U.S. patent system—long a driver of technology-fueled economic growth and envy of the world. Under the ...
Gateway - Quartz
Quartz· 2 days agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
Takara Bio, Jumpcode Genomics Cross-License CRISPR-Based RNA Depletion Tech
GenomeWeb News· 7 days agoTakara Bio and Jumpcode Genomics said Thursday that they have cross-licensed their respective intellectual property for CRISPR-based ribosomal RNA depletion. Both will continue to sell their ...
Cellect Your Weapon: Navigating Potential Arguments in the Aftermath of In re Cellect | JD Supra
JD Supra· 2 days agoIn In re Cellect, 81 F.4th 1216 (Fed. Cir. 2023), the US Court of Appeals for the Federal Circuit held that a later-expiring patent can be invalid for obviousness-type double patenting (ODP) ...
